Ginkgo Bioworks Holdings (DNA) Stock Statistics & Valuation Metrics

Ginkgo Bioworks Holdings has a market cap or net worth of MXN 14.19B. The enterprise value is MXN 714.39M.

Market Cap

MXN 14.19B

Enterprise Value

MXN 714.39M

Ginkgo Bioworks Holdings has 55,383,810 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

55,383,810

Owned by Insiders

3.85%

Owned by Institutions

35.07%

Ginkgo Bioworks Holdings’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -30.05%.

Return on Equity (ROE)

-0.61

Return on Assets (ROA)

-0.28

Return on Invested Capital (ROIC)

-30.05%

Return on Capital Employed (ROCE)

-0.31

Revenue Per Employee

350.84K

Profits Per Employee

-644.87K

Employee Count

485

Asset Turnover

0.15

Inventory Turnover

0.00

The current PE Ratio of Ginkgo Bioworks Holdings is -2.23. Ginkgo Bioworks Holdings’s PEG ratio is -0.14.

PE Ratio

-2.23

PS Ratio

6.75

PB Ratio

1.66

Price to FCF

-3.97

Price to Operating Cash Flow

-4.09

PEG Ratio

-0.14

In the last 12 months, Ginkgo Bioworks Holdings had revenue of 170.16M and earned -312.76M in profits. Earnings per share was -5.64.

Revenue

170.16M

Gross Profit

138.63M

Operating Income

-315.28M

Pretax Income

-313.60M

Net Income

-312.76M

EBITDA

-254.61M

Earnings Per Share (EPS)

-5.64

In the last 12 months, operating cash flow was -170.24M and capital expenditures -19.88M, giving a free cash flow of -190.12M billion.

Operating Cash Flow

-170.24M

Free Cash Flow

-190.12M

Free Cash Flow per Share

-3.06

Ginkgo Bioworks Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-25.19%

Earnings Yield

-41.78%

Beta

-0.34

52-Week Price Change

-59.52%

50-Day Moving Average

123.72

200-Day Moving Average

154.06

Relative Strength Index (RSI)

1.55

Average Volume (3m)

7,048

Ginkgo Bioworks Holdings upcoming earnings date is Nov 05, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 05, 2026

Next Earnings Date

Nov 05, 2026

Ex-Dividend Date

―

Ginkgo Bioworks Holdings as a current ratio of 4.92, with Debt / Equity ratio of 86.49%

Current Ratio

4.92

Quick Ratio

4.92

Debt to Market Cap

0.00

Net Debt to EBITDA

-1.07

Interest Coverage Ratio

0.00

In the past 12 months, Ginkgo Bioworks Holdings has paid -837.00K in taxes.

Income Tax

-837.00K

Effective Tax Rate

0.00

Ginkgo Bioworks Holdings EV to EBITDA ratio is -4.44, with an EV/FCF ratio of -5.65.

EV to Sales

9.61

EV to EBITDA

-4.44

EV to Free Cash Flow

-5.65

EV to Operating Cash Flow

-6.31

Ginkgo Bioworks Holdings has MXN 302.16M in cash and marketable securities with MXN 404.11M in debt, giving a net cash position of -MXN 101.95M billion.

Cash & Marketable Securities

MXN 302.16M

Total Debt

MXN 404.11M

Net Cash

-MXN 101.95M

Net Cash Per Share

-MXN 1.84

Tangible Book Value Per Share

MXN 6.05

Gross margin is 80.09%, with operating margin of -259.86%, and net profit margin of -259.96%.

Gross Margin

80.09%

Operating Margin

-259.86%

Pretax Margin

-264.14%

Net Profit Margin

-259.96%

EBITDA Margin

-216.35%

EBIT Margin

-263.68%

The average price target for Ginkgo Bioworks Holdings is MXN 149.30, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target

MXN 149.30

Price Target Upside

27.61% Upside

Analyst Consensus

Moderate Sell

Analyst Count

3

Revenue Growth Forecast

-55.16%

EPS Growth Forecast

15.73%

Smart Score

3

AI Score

―